• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生血管性年龄相关性黄斑变性患者的查尔斯·博内综合征:与质子泵抑制剂的关联

The Charles Bonnet Syndrome in Patients With Neovascular Age-Related Macular Degeneration: Association With Proton Pump Inhibitors.

作者信息

Leandro João Esteves, Beato João, Pedrosa Ana Catarina, Pinheiro-Costa João, Falcão Manuel, Falcão-Reis Fernando, Carneiro Ângela M

机构信息

Department of Ophthalmology, São João Hospital, Porto, Portugal.

Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal.

出版信息

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4138-4142. doi: 10.1167/iovs.16-21270.

DOI:10.1167/iovs.16-21270
PMID:28829845
Abstract

PURPOSE

We investigate the prevalence of the Charles Bonnet syndrome (CBS) in patients with neovascular age-related macular degeneration (AMD) and analyze the role of oral proton pump inhibitors (PPIs) and other potential risk factors.

METHODS

A total of 510 consecutive patients with neovascular-AMD followed at a single tertiary center in Portugal were screened for CBS. Using a structured questionnaire, psychiatrically healthy individuals were interviewed systematically and divided into a CBS group and a non-CBS group. Demographic data, current medication, and ocular risk factors were collected and compared between the two groups.

RESULTS

A total of 500 patients met the inclusion criteria and 471 with complete data were included in the final analysis. The prevalence of CBS was 9.0% (45/500). Using a binary logistic regression model, correlations were found between older age (P = 0.002), PPI intake (P = 0.022), poor visual acuity (P = 0.004), and development of CBS. PPIs doubled the risk of CBS from 7% (20/304) to 15% (25/167), with an odds ratio of 2.154. The increased risk for visual hallucinations caused by PPIs was independent of age (P = 0.598) and visual acuity (P = 0.739).

CONCLUSIONS

The prevalence of CBS in neovascular-AMD patients is high and mainly affects older individuals with poor visual acuity. PPIs seem to increase the risk of development of hallucinations independently of the degree of visual loss.

摘要

目的

我们调查了新生血管性年龄相关性黄斑变性(AMD)患者中查尔斯·邦尼特综合征(CBS)的患病率,并分析了口服质子泵抑制剂(PPI)及其他潜在危险因素的作用。

方法

对葡萄牙一家三级中心连续随访的510例新生血管性AMD患者进行CBS筛查。通过结构化问卷,对精神健康个体进行系统访谈,并分为CBS组和非CBS组。收集两组的人口统计学数据、当前用药情况及眼部危险因素并进行比较。

结果

共有500例患者符合纳入标准,471例数据完整的患者纳入最终分析。CBS的患病率为9.0%(45/500)。使用二元逻辑回归模型发现,年龄较大(P = 0.002)、服用PPI(P = 0.022)、视力差(P = 0.004)与CBS的发生相关。PPI使CBS的风险从7%(20/304)增加一倍至15%(25/167),比值比为2.154。PPI导致视幻觉风险增加与年龄(P = 0.598)和视力(P = 0.739)无关。

结论

新生血管性AMD患者中CBS的患病率较高,主要影响视力差的老年人。PPI似乎会独立于视力丧失程度增加幻觉发生的风险。

相似文献

1
The Charles Bonnet Syndrome in Patients With Neovascular Age-Related Macular Degeneration: Association With Proton Pump Inhibitors.新生血管性年龄相关性黄斑变性患者的查尔斯·博内综合征:与质子泵抑制剂的关联
Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4138-4142. doi: 10.1167/iovs.16-21270.
2
Clinical Characteristics of the Charles Bonnet Syndrome in Patients with Neovascular Age-Related Macular Degeneration: The Importance of Early Detection.新生血管性年龄相关性黄斑变性患者的 Charles Bonnet 综合征的临床特征:早期发现的重要性。
Ophthalmic Res. 2020;63(5):466-473. doi: 10.1159/000506137. Epub 2020 Jan 27.
3
The prevalence and clinical characteristics of Charles Bonnet Syndrome in Danish patients with neovascular age-related macular degeneration.丹麦新生血管性年龄相关性黄斑变性患者中 Charles Bonnet 综合征的患病率及临床特征。
Acta Ophthalmol. 2012 Aug;90(5):476-80. doi: 10.1111/j.1755-3768.2010.02051.x. Epub 2010 Nov 25.
4
Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome).年龄相关性黄斑变性患者的视力丧失与视幻觉(查尔斯·博内综合征)
Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1416-23. doi: 10.1167/iovs.06-0942.
5
Charles Bonnet syndrome in age-related macular degeneration: the nature and frequency of images in subjects with end-stage disease.年龄相关性黄斑变性中的查尔斯·博内综合征:晚期疾病患者图像的性质和频率
Ophthalmic Epidemiol. 2008 May-Jun;15(3):202-8. doi: 10.1080/09286580801939320.
6
What associates Charles Bonnet syndrome with age-related macular degeneration?是什么将查尔斯·博内综合征与年龄相关性黄斑变性联系起来?
Coll Antropol. 2010 Apr;34 Suppl 2:45-8.
7
Prevalence of Charles Bonnet syndrome in patients with age-related macular degeneration: systematic review and meta-analysis.年龄相关性黄斑变性患者中 Charles Bonnet 综合征的患病率:系统评价和荟萃分析。
Acta Ophthalmol. 2020 Mar;98(2):121-131. doi: 10.1111/aos.14287. Epub 2019 Oct 26.
8
Charles Bonnet Syndrome in Patients with Open-Angle Glaucoma: Prevalence and Correlation to Visual Field Loss.开角型青光眼患者的 Charles Bonnet 综合征:患病率及与视野缺损的相关性。
Ophthalmol Glaucoma. 2022 May-Jun;5(3):337-344. doi: 10.1016/j.ogla.2021.10.010. Epub 2021 Oct 21.
9
[Psychiatric, psychological comorbidities of typical and atypical Charles-Bonnet syndrome].[典型与非典型查尔斯·博内综合征的精神、心理共病情况]
Encephale. 2011 Dec;37(6):473-80. doi: 10.1016/j.encep.2011.05.006. Epub 2011 Jul 7.
10
Visual hallucinations and Charles Bonnet syndrome after photodynamic therapy for age related macular degeneration.年龄相关性黄斑变性光动力治疗后的视幻觉与查尔斯·邦尼特综合征
Br J Ophthalmol. 2003 Aug;87(8):977-9. doi: 10.1136/bjo.87.8.977.

引用本文的文献

1
Epidemiology and phenomenology of the Charles Bonnet syndrome in low-vision patients.低视力患者的 Charles Bonnet 综合征的流行病学和表现。
Int Ophthalmol. 2024 Sep 10;44(1):375. doi: 10.1007/s10792-024-03298-0.
2
The Charles Bonnet Syndrome: a Systematic Review of Diagnostic Criteria.查尔斯·博内综合征:诊断标准的系统评价
Curr Treat Options Neurol. 2019 Jul 25;21(9):41. doi: 10.1007/s11940-019-0582-1.